Kanaji N - Search Results

1

Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation.

Matsunaga T, Fukai F, Kameda T, Shide K, Shimoda H, Torii E, Kamiunten A, Sekine M, Yamamoto S, Hidaka T, Kubuki Y, Yokokura S, Uemura M, Matsuoka A, Waki F, Matsumoto K, Kanaji N, Ishii T, Imataki O, Dobashi H, Bandoh S, Shimoda K. Matsunaga T, et al. Among authors: kanaji n. Ann Hematol. 2012 Oct;91(10):1633-43. doi: 10.1007/s00277-012-1498-y. Epub 2012 May 29. Ann Hematol. 2012. PMID: 22644786

2

Small cell lung cancer associated with systemic sclerosis.

Kanaji N, Fujita J, Bandoh S, Fukumoto T, Ishikawa M, Haba R, Ishii T, Kubo A, Ishida T. Kanaji N, et al. Intern Med. 2005 Apr;44(4):315-8. doi: 10.2169/internalmedicine.44.315. Intern Med. 2005. PMID: 15897643 Free article. Review.

3

[A case of pulmonary actinomycosis, who expectorated sulfur granules, caused by Actinomyces odontolyticus and Actinomyces meyeri].

Susaki K, Bandoh S, Fujita J, Kanaji N, Ishii T, Kubo A, Ishida T. Susaki K, et al. Among authors: kanaji n. Nihon Kokyuki Gakkai Zasshi. 2005 Apr;43(4):231-5. Nihon Kokyuki Gakkai Zasshi. 2005. PMID: 15966370 Japanese.

4

HRCT shows variations in appearance in disseminated tuberculosis in adults.

Fujita J, Bandoh S, Kubo A, Ishii T, Kanaji N, Nakamura H, Higa F, Tateyama M, Ishida T. Fujita J, et al. Among authors: kanaji n. Int J Tuberc Lung Dis. 2006 Feb;10(2):222-6. Int J Tuberc Lung Dis. 2006. PMID: 16499265

5

[Monitoring the side effects of cancer chemotherapy with patients--participation of patients in cancer therapy and sharing patient information].

Kawazoe H, Kubo T, Iihara N, Doi C, Okujyoh M, Fukuoka N, Fujimoto S, Kanaji N, Bandoh S, Ishida T, Takiguchi Y, Houchi H. Kawazoe H, et al. Among authors: kanaji n. Yakugaku Zasshi. 2006 Aug;126(8):629-42. doi: 10.1248/yakushi.126.629. Yakugaku Zasshi. 2006. PMID: 16880721 Free article. Japanese.

6

Compensation of type I and type II cytokeratin pools in lung cancer.

Kanaji N, Bandoh S, Fujita J, Ishii T, Ishida T, Kubo A. Kanaji N, et al. Lung Cancer. 2007 Mar;55(3):295-302. doi: 10.1016/j.lungcan.2006.11.004. Epub 2006 Dec 8. Lung Cancer. 2007. PMID: 17161499

7

Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.

Yamamoto Y, Nishiyama Y, Ishikawa S, Nakano J, Chang SS, Bandoh S, Kanaji N, Haba R, Kushida Y, Ohkawa M. Yamamoto Y, et al. Among authors: kanaji n. Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1610-6. doi: 10.1007/s00259-007-0449-7. Epub 2007 May 26. Eur J Nucl Med Mol Imaging. 2007. PMID: 17530250

8

Preventive effects of low-dose dexamethasone for delayed adverse events induced by carboplatin-based combination chemotherapy.

Kawazoe H, Takiguchi Y, Tanaka H, Doi C, Fukuoka N, Kanaji N, Bandoh S, Ishida T, Houchi H. Kawazoe H, et al. Among authors: kanaji n. Yakugaku Zasshi. 2007 Jun;127(6):1001-6. doi: 10.1248/yakushi.127.1001. Yakugaku Zasshi. 2007. PMID: 17541251 Free article.

9

[Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer].

Kanaji N, Bandoh S. Kanaji N, et al. Nihon Kokyuki Gakkai Zasshi. 2007 Jun;45(6):474-8. Nihon Kokyuki Gakkai Zasshi. 2007. PMID: 17644943 Japanese.

10

Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.

Yamamoto Y, Nishiyama Y, Kimura N, Ishikawa S, Okuda M, Bandoh S, Kanaji N, Asakura M, Ohkawa M. Yamamoto Y, et al. Among authors: kanaji n. Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):236-45. doi: 10.1007/s00259-007-0613-0. Epub 2007 Oct 2. Eur J Nucl Med Mol Imaging. 2008. PMID: 17909790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page